A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Replimune Inc.
Shanghai Juncell Therapeutics
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Celldex Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Rochester
Revolution Medicines, Inc.
Silverback Therapeutics
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.